Peptide Based Cancer Therapeutics Market Size Worth $23.13 Billion By 2034 | CAGR: 10.2%

The global peptide based cancer therapeutics market size is expected to reach USD 23.13 billion by 2034 according to a new study by Polaris Market Research. The report “Peptide Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Therapeutic anticancer peptides, Peptide cancer vaccines, PDCs, PRRT, Cell-penetrating / tumor-homing peptides, Hormonal peptide therapies, Other); By Cancer Type; By Mode of Mechanism, By Distribution Channe, By Regions; Segment Forecast, 2026 –2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Peptides are compounds that are created by natural or artificial biological linking of amino acid monomers. Peptides are being widely used in therapeutics to treat several ailments, including cancer owing to their precision based nature, targeting solid tumor cells in the body. Peptide based cancer therapeutics have shown effective results against cancer as opposed to conventional cancer treatments, without much side effects.

Peptide based therapies in the treatment of cancer are majorly classified as pure play peptide therapy, vaccines based on peptide, and peptide conjugate nanomaterials. These therapies possess several advantages over others such as easy administration, specificity in targeting tumor tissues, fewer side effects as compared to drugs, and low cost of peptides.

Rising investment in oncology research and clinical trials is driving the development of peptide-based cancer therapeutics. Pharmaceutical and biotechnology companies are focusing on discovering novel peptides that can selectively target cancer cells while minimizing damage to healthy tissues. Government funding, research collaborations, and partnerships between academic institutions and drug developers are supporting innovation. The growing pipeline of peptide-based candidates is expanding treatment possibilities and strengthening the market's long-term growth prospects.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: Peptide Based Cancer Therapeutics Market Report

The increasing demand for targeted cancer treatments is supporting the adoption of peptide-based therapeutics. These treatments can interact with specific receptors or molecular targets associated with cancer cells, potentially improving treatment precision and reducing unintended effects on healthy tissues. As patients and healthcare providers seek more personalized treatment options, interest in peptide-based approaches continues to increase. Advances in peptide design and drug delivery are further improving their therapeutic potential across different cancer types.

Peptide Based Cancer Therapeutics Market report on the basis of drug type, cancer type, mode of mechanism, distribution channel, and region

By Drug Type Outlook (Revenue – USD Billion, 2021–2034)

• Therapeutic anticancer peptides
• Peptide cancer vaccines
• PDCs
• PRRT
• Cell-penetrating / tumor-homing peptides
• Hormonal peptide therapies
• Other

By Cancer Type Outlook (Revenue – USD Billion, 2021–2034)

• Lung
• Breast
• Prostate
• Colorectal
• Melanoma
• Stomach
• Neuroendocrine
• Pancreatic
• Ovarian
• Hematological
• Brain/CNS
• Biliary tract
• Other solid

By Mode of Mechanism Outlook (Revenue – USD Billion, 2021–2034)

• Receptor-targeting
• Apoptosis-inducing
• Immune-modulating
• Angiogenesis-inhibiting
• Cell-penetrating
• Tumor-homing
• PDCs

By Distribution Channel Outlook (Revenue – USD Billion, 2021–2034)

• Hospital pharmacies
• Specialty and retail pharmacies
• Online pharmacies

By Regional Outlook (Revenue – USD Billion, 2021–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Peptide Based Cancer Therapeutics Market Report Scope

Report Attributes	Details
Market size value in 2025	USD 9.67 billion
Market size value in 2026	USD 10.65 billion
Revenue forecast in 2034	USD 23.13 billion
CAGR	10.2% from 2026 – 2034
Base year	2025
Historical data	2021 – 2024
Forecast period	2026 – 2034
Quantitative units	Revenue in USD billion and CAGR from 2026 to 2034
Segments Covered	By Drug Type, By Cancer Type, By Mode of Mechanism, By Distribution Channel
Regional scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Customization	Report customization as per your requirements with respect to countries, region, and segmentation

Source: Polaris Market Research Analysis